XENOTHERA
Nantes, France · Founded 2014
- Headquarters
- Nantes
- Founded
- 2014
- Business Model
- B2B
- Website
- xenothera.com
About
XENOTHERA is a Nantes-based biotech company founded in 2014 that develops glyco-humanized polyclonal antibodies through its proprietary technological platform. Its lead therapeutic candidate, XAV-19, targets severe infections, and the company operates a unique therapeutic farm in France to produce its antibody treatments. XENOTHERA is also expanding its platform into oncology, including a candidate for peripheral T-cell lymphoma.
Summary
XENOTHERA is a Biotech company based in Nantes, France, founded in 2014.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/xenothera"><img src="https://indexed.vc/api/badge/company/xenothera" alt="XENOTHERA on Indexed.vc" width="260" height="76" /></a>